×
S&P 500   3,792.31 (-0.86%)
DOW   30,671.16 (-1.37%)
QQQ   283.63 (+0.53%)
AAPL   139.98 (+0.76%)
MSFT   259.62 (+0.02%)
META   165.29 (+3.29%)
GOOGL   2,234.83 (+2.76%)
AMZN   112.90 (+3.05%)
TSLA   688.50 (+0.98%)
NVDA   148.16 (+2.02%)
NIO   21.77 (+1.92%)
BABA   116.73 (+0.63%)
AMD   74.36 (+0.94%)
MU   55.89 (+4.18%)
CGC   2.64 (-6.05%)
T   20.95 (-1.69%)
GE   61.19 (-3.70%)
F   11.05 (-2.39%)
DIS   95.95 (-0.20%)
AMC   12.71 (-6.06%)
PFE   50.97 (-2.56%)
PYPL   73.62 (+3.11%)
NFLX   183.25 (+1.83%)
S&P 500   3,792.31 (-0.86%)
DOW   30,671.16 (-1.37%)
QQQ   283.63 (+0.53%)
AAPL   139.98 (+0.76%)
MSFT   259.62 (+0.02%)
META   165.29 (+3.29%)
GOOGL   2,234.83 (+2.76%)
AMZN   112.90 (+3.05%)
TSLA   688.50 (+0.98%)
NVDA   148.16 (+2.02%)
NIO   21.77 (+1.92%)
BABA   116.73 (+0.63%)
AMD   74.36 (+0.94%)
MU   55.89 (+4.18%)
CGC   2.64 (-6.05%)
T   20.95 (-1.69%)
GE   61.19 (-3.70%)
F   11.05 (-2.39%)
DIS   95.95 (-0.20%)
AMC   12.71 (-6.06%)
PFE   50.97 (-2.56%)
PYPL   73.62 (+3.11%)
NFLX   183.25 (+1.83%)
S&P 500   3,792.31 (-0.86%)
DOW   30,671.16 (-1.37%)
QQQ   283.63 (+0.53%)
AAPL   139.98 (+0.76%)
MSFT   259.62 (+0.02%)
META   165.29 (+3.29%)
GOOGL   2,234.83 (+2.76%)
AMZN   112.90 (+3.05%)
TSLA   688.50 (+0.98%)
NVDA   148.16 (+2.02%)
NIO   21.77 (+1.92%)
BABA   116.73 (+0.63%)
AMD   74.36 (+0.94%)
MU   55.89 (+4.18%)
CGC   2.64 (-6.05%)
T   20.95 (-1.69%)
GE   61.19 (-3.70%)
F   11.05 (-2.39%)
DIS   95.95 (-0.20%)
AMC   12.71 (-6.06%)
PFE   50.97 (-2.56%)
PYPL   73.62 (+3.11%)
NFLX   183.25 (+1.83%)
S&P 500   3,792.31 (-0.86%)
DOW   30,671.16 (-1.37%)
QQQ   283.63 (+0.53%)
AAPL   139.98 (+0.76%)
MSFT   259.62 (+0.02%)
META   165.29 (+3.29%)
GOOGL   2,234.83 (+2.76%)
AMZN   112.90 (+3.05%)
TSLA   688.50 (+0.98%)
NVDA   148.16 (+2.02%)
NIO   21.77 (+1.92%)
BABA   116.73 (+0.63%)
AMD   74.36 (+0.94%)
MU   55.89 (+4.18%)
CGC   2.64 (-6.05%)
T   20.95 (-1.69%)
GE   61.19 (-3.70%)
F   11.05 (-2.39%)
DIS   95.95 (-0.20%)
AMC   12.71 (-6.06%)
PFE   50.97 (-2.56%)
PYPL   73.62 (+3.11%)
NFLX   183.25 (+1.83%)

Adverum Biotechnologies Insider Trading & Ownership

$1.16
-0.02 (-1.69%)
(As of 07/5/2022 01:56 PM ET)
Add
Compare
Today's Range
$1.16
$1.19
50-Day Range
$0.81
$1.20
52-Week Range
$0.80
$3.66
Volume
22,951 shs
Average Volume
1.52 million shs
Market Capitalization
$114.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50

Adverum Biotechnologies (NASDAQ:ADVM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.40%
Number Of
Insiders Buying
(Last 12 Months)
5
Amount Of
Insider Buying
(Last 12 Months)
$178,806.33
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$119,342.22

ADVM Insider Buying and Selling by Quarter

Get ADVM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adverum Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Adverum Biotechnologies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/23/2022Setareh SeyedkazemiInsiderBuy20,000$0.84$16,800.0020,600  
5/17/2022Rupert D'souzaCFOBuy10,000$0.83$8,300.0020,850  
5/16/2022Dawn SvoronosDirectorBuy30,000$0.85$25,500.0050,000  
5/13/2022Rupert D'souzaCFOBuy10,000$0.86$8,600.0010,850  
4/20/2022Laurent FischerCEOBuy25,000$1.11$27,750.00762,462  
4/19/2022Peter SoparkarInsiderBuy21,925$1.14$24,994.50280,556  
12/8/2021Laurent FischerCEOBuy10,677$1.79$19,111.83  
12/8/2021Peter SoparkarInsiderBuy25,000$1.91$47,750.00  
11/15/2021James Paul ScopaDirectorSell50,000$2.18$109,000.00  
9/30/2021Julie ClarkInsiderSell4,766$2.17$10,342.22  
3/24/2021Laurent FischerCEOBuy10,000$9.88$98,800.0026,292  
2/9/2021Leone D PattersonCFOSell12,533$14.10$176,715.3098,017  
1/15/2021Laurent FischerCEOBuy8,600$11.53$99,158.0016,292  
1/15/2021Patrick MachadoDirectorBuy10,000$11.52$115,200.0078,182  
8/17/2020Peter SoparkarinsiderBuy7,692$13.00$99,996.007,692  
7/20/2020Mehdi GasmiDirectorSell5,000$17.60$88,000.00279,442  
6/22/2020Mehdi GasmiDirectorSell23,605$25.06$591,541.30298,047  
6/18/2020Mehdi GasmiDirectorSell11,395$25.01$284,988.95274,710  
6/16/2020Leone D PattersonPresidentSell13,171$24.68$325,060.28110,488  
6/15/2020Mehdi GasmiDirectorSell10,000$21.86$218,600.00284,442  
5/20/2020Mehdi GasmiDirectorSell1,401$20.01$28,034.01275,843  
5/18/2020Mehdi GasmiDirectorSell5,000$18.17$90,850.00  
5/6/2020Leone D. PattersonCEOSell20,000$20.02$400,400.00  
5/6/2020Mehdi GasmiDirectorSell25,000$20.03$500,750.00  
3/20/2020Leone D PattersonCEOSell39,526$10.17$401,979.42162,955  
3/17/2020Leone D PattersonCEOSell474$10.02$4,749.48138,531  
2/14/2020James Paul ScopaDirectorBuy10,000$15.79$157,900.00  
2/12/2020Mehdi GasmiDirectorSell10,000$15.07$150,700.00321,418  
5/6/2019James Paul ScopaDirectorBuy20,000$6.71$134,200.00  
6/8/2015Mehdi GasmiVPSell500$38.64$19,320.00  
6/8/2015Paul WachterDirectorSell1,192$38.64$46,058.88  
5/26/2015Paul WachterDirectorSell1,192$36.94$44,032.48  
5/22/2015Steven Daniel SchwartzDirectorSell16,875$38.38$647,662.50  
5/13/2015Linda BainCFOSell285$34.94$9,957.90  
5/13/2015Mark S BlumenkranzDirectorSell715$34.94$24,982.10  
5/8/2015Steven Daniel SchwartzDirectorSell17,250$33.05$570,112.50  
4/28/2015Mehdi GasmiVPSell1,000$35.67$35,670.00  
4/27/2015Paul WachterDirectorSell1,192$35.61$42,447.12  
4/23/2015Steven Daniel SchwartzDirectorSell16,875$38.62$651,712.50  
4/21/2015Mehdi GasmiVPSell1,000$39.21$39,210.00  
4/20/2015Paul WachterDirectorSell1,192$40.19$47,906.48  
4/16/2015Mark S BlumenkranzDirectorSell25,000$41.59$1,039,750.00  
4/14/2015Zygtech, LlcMajor ShareholderSell25,000$39.55$988,750.00  
4/13/2015Paul WachterDirectorSell1,192$39.34$46,893.28  
4/9/2015Steven Daniel SchwartzDirectorSell17,250$39.73$685,342.50  
4/7/2015Hans HullSVPSell27,500$38.60$1,061,500.00  
4/7/2015Mehdi GasmiVPSell9,000$38.60$347,400.00  
8/5/2014James E FlynnInsiderBuy1,334,467$23.92$31,920,450.64  
8/5/2014Regeneron Pharmaceuticals IncMajor ShareholderBuy588,235$17.00$9,999,995.00  
(Data available from 1/1/2013 forward)












Adverum Biotechnologies Insider Trading - Frequently Asked Questions

Who is on Adverum Biotechnologies's Insider Roster?

The list of insiders at Adverum Biotechnologies includes Dawn Svoronos, James Paul Scopa, Julie Clark, Laurent Fischer, Leone D Patterson, Mehdi Gasmi, Patrick Machado, Peter Soparkar, Rupert D'souza, and Setareh Seyedkazemi. Learn more on insiders at ADVM.

What percentage of Adverum Biotechnologies stock is owned by insiders?

12.40% of Adverum Biotechnologies stock is owned by insiders. Learn more on ADVM's insider holdings.

Which Adverum Biotechnologies insiders have been buying company stock?

The following insiders have purchased Adverum Biotechnologies stock in the last 24 months: Dawn Svoronos ($25,500.00), Laurent Fischer ($244,819.83), Patrick Machado ($115,200.00), Peter Soparkar ($172,740.50), Rupert D'souza ($16,900.00), and Setareh Seyedkazemi ($16,800.00).

How much insider buying is happening at Adverum Biotechnologies?

Insiders have purchased a total of 188,894 Adverum Biotechnologies shares in the last 24 months for a total of $591,960.33 bought.

Which Adverum Biotechnologies insiders have been selling company stock?

The following insiders have sold Adverum Biotechnologies stock in the last 24 months: James Paul Scopa ($109,000.00), Julie Clark ($10,342.22), Leone D Patterson ($176,715.30), and Mehdi Gasmi ($88,000.00).

How much insider selling is happening at Adverum Biotechnologies?

Insiders have sold a total of 72,299 Adverum Biotechnologies shares in the last 24 months for a total of $384,057.52 sold.

This page (NASDAQ:ADVM) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.